Aptose Biosciences Inc (APS : TSX)
Common Stock
$2.40
CAD
+0.00 (%)
Last updated: 2026-07-03
Get APS alerts:
APS
Aptose Biosciences Inc
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+0.00%
1 Month
+0.00%
YTD
+18.81%
Key Statistics
Market Cap
$6.13M
52W High
$2.59
52W Low
$1.41
P/E Ratio
-
50 Day MA
$2.25
200 Day MA
$2.14
Beta
0.34
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/3/2026 | $2.40 | $2.40 | $2.40 | $2.40 | $2.40 | 2,945 |
| 7/2/2026 | $2.40 | $2.41 | $2.40 | $2.40 | $2.40 | 32,232 |
| 6/30/2026 | $2.13 | $2.14 | $2.13 | $2.14 | $2.14 | 200 |
| 6/29/2026 | $2.25 | $2.25 | $2.25 | $2.25 | $2.25 | 0 |
| 6/26/2026 | $2.20 | $2.25 | $2.20 | $2.25 | $2.25 | 305 |
| 6/25/2026 | $2.20 | $2.20 | $2.20 | $2.20 | $2.20 | 100 |
| 6/24/2026 | $2.20 | $2.20 | $2.20 | $2.20 | $2.20 | 3,010 |
| 6/23/2026 | $2.12 | $2.13 | $2.12 | $2.13 | $2.13 | 1,100 |
| 6/22/2026 | $2.08 | $2.20 | $2.08 | $2.12 | $2.12 | 1,196 |
| 6/19/2026 | $2.20 | $2.20 | $2.20 | $2.20 | $2.20 | 0 |
Analyst Price Targets
Based on analyst covering APS
Wall Street analysts forecast APS stock price to fall 1.7% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.36
-1.7% Upside
Current Price
C$2.40
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APS's historical volatility
30-Day Vol
52.7%
Annualized
90-Day Vol
48.9%
Annualized
Trend (90d)
-0.0%
Annualized drift
90d Mean
C$2.40
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.40 | C$2.00 – C$2.88 |
| 60 trading days | C$2.40 | C$1.86 – C$3.10 |
| 90 trading days | C$2.40 | C$1.75 – C$3.29 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Aptose Biosciences Inc
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company's clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed Phase 1/2 clinical trial targeting a select group of kinases operative in myeloid malignancies, such as acute myeloid leukemia and the higher risk myelodysplastic syndromes. It has license agreements with National Cancer Institute for the clinical development of tuspetinib; and Hanmi Pharmaceutical Co Ltd. to research, develop, and commercialize tuspetinib. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-26.42M
- Profit Margin
- 0.00%
- ROE (TTM)
- -694.13%
- EPS (Diluted)
- -14.78
- Book Value
- -19.30
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About APS
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| AAB | Aberdeen International Inc. | $0.03 | +50.00% |
| S | Sherritt International Corporation | $0.26 | +27.50% |
| ACB | Aurora Cannabis Inc | $5.03 | +24.81% |
| OGI | OrganiGram Holdings Inc | $1.69 | +18.18% |
| FRX | Fennec Pharmaceuticals Inc | $17.63 | +15.38% |
| COPR | Coppernico Metals Inc. | $0.46 | +15.00% |
| STLR | STLLR Gold Inc. | $1.77 | +14.94% |
| ORIO | Orion Digital Corp. | $1.12 | +12.00% |
APS.TO news timeline
15 articles covering APS.TO, most recent first
LatestWhat's Going On With Aptose Biosciences Inc Stock Monday?
July 2026
- What's Going On With Aptose Biosciences Inc Stock Monday?
- What's Going On With Aptose Biosciences Inc Stock Monday?
- What's Going On With Aptose Biosciences Inc Stock Monday?
- Why Aptose Biosciences Inc stock is skyrocketing today
- Why Aptose Biosciences Inc stock is skyrocketing today
- Why Aptose Biosciences Inc stock is sliding today
June 2026
- Why Aptose Biosciences Inc stock is plummeting today
- Why Aptose Biosciences Inc stock is rising today
- Why Aptose Biosciences Inc stock is rising today
- Why Aptose Biosciences Inc stock is sliding today
- Why Aptose Biosciences Inc stock is rising today
- Why Aptose Biosciences Inc stock is plummeting today
- Why Aptose Biosciences Inc stock is skyrocketing today